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N orm al human serum contain s a 230,000 M,. pro tein that 
inhibits fib rob last chem otacti c and rando m mig ration. T his 
serum inhibi to r of fibro blast mig rati on (S IFM ) is a heat-
stable, tr ypsin-sensitive pro tein w ith a pI of 4.8 that re-
versibl y inhibi ts the rando m and chem otactic mig ration of 
fi broblasts in vitro. Alth ough SIFM effectivel y inhibi ts the 
chem otax is of fibro bl as ts to interstiti al co ll agens, fibro-
nectin , ly mph ocy te-deri ved chem otacti c fac to r fo r fi bro-
blas ts, and serum-de ri ved chem otacti c facto r, it does no t 
Fibro blasts mi g rate to areas of tiss ue injury and inflam-mati o n, pro li ferate, and effect repa i'r by sy nthes izing new matrix. Fib rob last m ig rat io n to sites of tissue injury may be in d uced by specific chell1 oattractants. It has been ob-served that human fi broblasts recogni ze at least 6 d if-
fe ren t classes of chemoattractants in v itro. T hese in clude (1) native 
type I, II , and III co lla gens, purifi ed collagen Oi chains, and hy-
d roxypro line-co nta ining pe ptides, (2) lymphocyte-de ri ved che-
motactic facto r fo r fib rob lasts (LDCF-F), (3) serum-der ived che-
motacti c fac tor (SDCF) , (4) fib ronectin , (5) plate let-derived growth 
fac tor, and (6) elastin-de ri ved peptides [1-7]. 
A lthoug h these fi ndin gs suggest th :lt natural mechanisms ex ist 
fo r the recruitm en t of the loca l fi brob la st poo l in to areas of tiss ue 
da mage, it is also reaso nable to pos tulate that such mi g rat ion must 
be terminated and contro ll ed in some mann er. In this report, we 
have observed th at no rl11a l human serum conta ins an inhi bito r of 
fibro blast mi g ration. T his se rul11 inhi bito r of fib roblast mi gration 
(S IFM) ap pea rs to be a rela tive ly stab le, large-molecula r-weig ht 
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Abbreviations: 
GGES: 0.0075 M g lycy lg lyc ine/0.1 4 M N aC1, pH 7.2 
IEF; isoelectri c focll sin g 
LDCF-F: lym phocyte-deri ved chelllot:lct ic f.1cto r fo r fibro bhsts 
M EM : EJglc's m inim um essen tial m edi um 
0 1F: o il immersion fie lds 
SBTI: soybea n tryps in inh ibitor 
SO F: se ru m-derived chem otact ic fJcto r 
SIFM : sc rum inhi bito r of fib roblas t m igrat ion 
alter the chem otacti c mig ration of hum an peripheral blood 
neutrophils o r monocytes, and does not act as a cy to toxin 
to human de rm al fi broblas ts. T he SIFM appea rs to act 
through a cell-d irected m echanism to alter the fibroblas t 's 
abili ty to mig rate. Serum inhibitor of fi broblast mig ration 
may fun ction in v ivo to modulate fibroblas t mig ration un-
der ph ysio logic and patho logic conditions. J blllest DermatoJ 
88:183-190, 1987 
protein ca pable o f effecti vely red ucing both the rando m and che-
motactic mi g ration of fi broblasts in vitro. Furth erm ore, this fac-
to r appea rs to specifi call y inhibit the m igration of fib roblas ts and 
has no effect on th e m igrat ion of 111 0 nocytes or neutro phil s. 
MATEHIA LS AN D METH ODS 
Fibroblast Chcn'lotaxis Fibroblas t chemo taxis was measured 
by meth ods described prev iously [2J. N o rm al human in fa nt 
foresk in fib ro blas ts m ain tai ned in mo no layer culture were used 
as ind icator cell s in the assay [4]. Serum-free suspensions of har-
ves ted fi bro blasts were loaded in to the upper compartments of 
blind-w ell chcmotax is cham bers (D uke University Su rgica l In-
strum ent Sho p, D urham , N orth Ca rolin a) cquip ped w ith po ro us 
(8 IJ-m) gelat in- o r ethano l-trea ted po lyca rbo nate fi lters. Test sub-
sta nces were placed in th c lower compartmen t below the fi lter. 
After a 150-min incubation at 37°C in a humidi ficd atm os phere 
co ntaining 5% CO2 , the fi lters were rem oved fro m each chamber 
and stained w ith hcmatoxy lin . C hemo taxis was q uanti tated by 
countin g th e number of fi bro blas ts th at mig rated throug h the 
po res to thc lower surface of cach fi lter in a to tal of20 rando ml y 
selected oil immersio n fie lds (O IF, 600 x magni ficat ion). All sa m-
ples were tcsted in triplicate. Final chemo tactic acti vity was ex-
pressed as the mea n ± SEM of the replicatcs. 
Fibroblast Chemoattractants Fibroblast chemoattractants [type 
III human sk in collagen, heat-denatured bovin e type I coll agen 
(gelatin), LDCF- F, SD CF, and human pl as ma fi bro nectin ] were 
prepa red as described elsewhere [1-4J. 
Monocy te and N eutrophil Chemotaxis Human peri pheral 
blood monocyte and neu tro phil chemotax is were q uant itated by 
meth ods publ ished previo usly [81. Pa rti all y purified human C5a, 
isolated by Sephadex G-200 chro m atograph y of zy m osa n-acti-
vated serum , kallikrein (Sig ma C hemica l Co., St. Lo uis, Mis-
souri ), and gela ti n scrved as chemoa tt ractan ts [3]. 
Migration Inhibition T he inhi bition of fib roblast migrat ion 
by SIFM was quanti tatcd as foll ows. In a sta nda rd fi broblas t 
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chemo tax is assay, samples containin g SIFM were diluted in ().0075 
M g lycy lg lycine/0.1 4 M N aC I, pH 7 .2 (GGB S) as indi ca ted and 
added w ith or w ithout che llloa ttractants to the lower compart-
ment of chem o ta x is chal11bers 121. Loaded chambers were in cu-
bated for 150 min (with chemoattractants) o r 210-240 min (w ith-
out chemoattracta nts) at 37°C in a humidifi ed atmosphere containing 
5% CO~ . The lo nger in cubati o n tim e of chambers witho ut che-
moa ttrac tants was necessary [0 all ow in creased numbers of fi-
bro blasts to mig rate ra ndom ly thro ug h the filter pores. Fibroblast 
mi g ratio n throu gh cach chemo ta xis fi lte r was quantitated , and 
percent inhibitio n o f mi g ratio n was ca lcu lated by th e fo ll owin g 
formula: 
Percen t inhibition 
Control mi g ration - Ex pcrimenta l mig rat ion 
-------'''----------'------'''--- x l 00. 
Contro l mi g ratio n 
In so me experim ents, SIFM act ivity was expressed in units. 
O ne unit of acti vity was defin ed as the amount of SIFM givi ng 
50% inhibitio n of rand o m mi g rati o n o f fibro blasts (m igrati o n 
observed w ithout chell1oattra ctants) . To ca lcu late the nUlllber of 
units in co ncen trated sa mpl es, the reciprocal of th e di lu ti on g iving 
50% inhibition o f random mi g rati o n was used to des ignate tota l 
units in the lower compartm ents (200 J.LI vo lulll e) of the modified 
Boyden cham bers. 
Isolation of Serum Who le blood was o btained by ven ipuncture 
fro m normal hum an donors. Coll ected blood was all owed to clot 
in g lass tubes at rOO I11 te mperature. After centrifu ga ti on at 500 g 
for 10 min at 25°C, the serum was removed fro m each tube. 
Partial Purification of SIFM Ammon ium sul f.He (ultrapure, 
Schwa rtz/Mann , Ora ngeburg, N ew York) was added sequ en-
tia ll y at different co ncentrations to se rum to achieve va rio us de-
g rees of sa turation . Precipitat io n was ca rri ed o ut at roo m tem-
perature w ith consta nt s tirrin g. T he precip itate was coll ected after 
each centrifu ga ti on, red isso lved in dist ill ed water, and :t1i quots 
(11 ml) containing SIFM act ivity (35-55% saturation) were sub-
j ected to preparative gel fi ltrati on. 
Gel fi ltratio n was perfo rm ed o n a co lullln 4.5 cm in di amete r 
and 54 cm in length previously packed with Sephadex G-1 50 
(Pharma cia Fine C hemica ls, Piscataway, N ew Jersey) . The co l-
umn was run w ith 0.01 M Tris-H C I buffer, pH 8.0, at 4° . 
Column effl uent was continu ously m oni to red fo r absorbance at 
280 nm w ith a Pharm acia M odel 200 reco rding spectro photo-
mete r. An aliq uo t (1.0 Illl ) of each fra ction was removed, dial yzed 
extcnsively agai nst GGE S at 4°C, and assayed for its ability to 
inhibit fibro blast mig ratio n. 
Poo led , active fractions from Sephadex G-150 chro matograph y 
we re subj ected to anio n exchange ch romatograp hy o n a 2.5 Clll 
diam eter X 10 cm length co lu mn of DE-52 cellulose (Wh atm an) 
equi librated prev io usly with 0.01 M T ri s-HC I buffer, pH 8.0, at 
4°C . A stepw ise elu tio n was perform ed with 0.07 M and 0.2 M 
N aCl/O.01 M Tris-HCl, pH 8. Anal yses revealed that SIFM ac-
ti vity was present in th e 0 .2 M fra ctio n. T he 0.2 M fract ion was 
concentrated l OO-fo ld in an Amicon ultrafiltration cell fitted w ith 
a PM-30 membrane (A mi con Corp ., Lex ington, Massachuset ts). 
T he concentrated 0.2 M fraction was dial yzed ex ten sively against 
disti lled water at 4°C. After dialysis, precipitated materi al was 
rem o ved by centrifuga ti on , and the supern ata nt was coll ected. 
Coll ected supern atant was ad ded to a slurry of Seph adex G-75 
superfin e (lEF Seph adex) as fo ll ows. Ampho line, pH 4-6.5 (Phar-
m 3cia Fine C hemi ca ls) was added to the Sephadex slurry. The 
slurry was po ured to for m a 250 mm x 250 mm x 4 n1m gel 
and eva porated to 70% of the swollen gel weight. A 1 % am-
pho Li nc so lu tion was used for both ano ly te and catho lyte . Run-
nin g condi tions wen; 300 W ho urs at 5°C usin g a Pharm acia FEE 
3000 constant power suppl y conn ected to a Pharmacia Aatbed 
isoelcctric focusing (l EF) unit . Const:lIlt temperatu re was main-
tained b y using a Haake Model FE coo ling bath (Haake , Berli n , 
Wes t Germ any) . Foll ow ing produ ctio n o f a replica o n Whatman 
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#2 fi lter paper, the gel bed was divided into 26 fra ctio ns. A 
po rtion o f each frac tion was placed in distilled water (2 ml) to 
es tab lish a pH g radient, and the remaindcr was eluted with GGBS. 
Thesc fractio ns were dia lyzed ex tensive ly against GGES and as-
sa yed for SIFM act ivity. Active fractions were pooled, co ncen-
trated by press ure ultrafi ltration, and loaded onto a co lumn 2.5 
cm in di ameter and 100 cm in leng th packed w ith Scphadex G-
200 eq uilibrated w ith GGES. Fractions containin g SIFM activity 
were poo led, co ncentrated , and rechro matograph ed on the sa m e 
G-200 column . T hi s partiall y purifIed SIFM w as used in ph ysi-
ochemica l, cyto toxicity, and monocyte and neutrophil chem o-
taxis stud ies. 
Molecular Weight Estimation The SIFM purified by 
(NH.1hS04 precipitation (35-55% cut) was subj ected to gel ftl-
trat ion o n a co lumn 2.5 cm in diameter and 100 Clll in leng th 
packed w ith Biogel A 1. 5M (Bio- lbd, Richm ond , Ca li fornia). 
T he column was prev ious ly equi li brated with GG nS and ca li-
brated w ith proteins of known molecular weight. A drop of 
tritiated wate r (N ew En g land Nuclea r, Boston, Massachusetts) 
was added to each sa lllple to mark the colullln vo lu lll e. T he 
efflu ent was mo nito red fo r abso rbance as described above, and 
all eluted fracti ons we re tested fo r SIFM activity in the sa me assay. 
Physiochemical Characterization of SIFM The th erm al sta-
bility o f SIFM was assessed as fo llows. Aliquots o f partiall y pu-
rified SIFM were heated to 56°C fo r 45 min or 80°C for 3 min. 
Samp les were centrifu ged , and th e supern atants were tested fo r 
th eir abilit y to inhibit fibroblast mi g ration. 
To determin e w hether SIFM was a pro tein, SIFM (14.7 units 
in 300 J.Ll GGBS) was incubated for 150 min at 37°C w ith TPCK 
trypsin (20 units, 2 J.Lg, Sig ma C hemi cal Co .) in 300 J.LI of serUl11-
free Eagle 's minimum essentia l med ium (M E M , G ibco, G rand 
[sland, N cw Yo rk). Trypsin was then inactivated by add ition of 
a 5-fo ld excess o f soy bea n trypsin inhibito r (SBTl) (Sig ma C hel11-
ical Co.). As a comrol, an identica l sam ple o fSIFM was incubated 
w ith SBTI fo r 150 min and th en trypsin was added to the mixture, 
All sa mples were tested fo r their effect on fibroblast mi gration 
in the sa me :l5say. 
Cytotoxicity To analyze for potential cyto toxic effects of SIFM , 
washed fibro blas ts werc suspended in M EM with and w ithout 
the addition of partiall y purifi ed SIFM . The suspended cell s were 
in cubated at 37°C in a humidifi ed atm os phere containing 5% CO2 
fo r 3 h . Cells were then tested for viability by trypan blue ex-
cl usio n. Alternately, the effects o f SIFM 0 11 thymine uptake and 
in co rpo rat ion in to DN A were stud ied by pl ating fibro blasts at 
low den sity 005 cells/well ) in Falcon 3003 multi well plates (Falcon 
Plastics, O xnard , Ca lifo rni a) in M EM supplem ented with 10% 
feta l calf se rum , peni cillin (100 U / ml) , strepto m ycin (100 J.Lg/ml), 
amphoteracin 13 (l J.Lg/ml), and nonessentia l am ino acids as de-
scri bed previo usly [8]. Prepared plates were incubated at 37°C in 
a hu midified atm osphere con tainin g 5% CO2 for 16 h. Adherent 
cell s were washed 3 tiIll es with serum-free M E M . Minimum 
essenti al medium (200 J.LJ) and GGBS (200 J.LI) or partially purifi ed 
SIFM (sterilized by mi cro po re filtration) were then added to ap-
propriate well s. C ul tures were placed in incubation for 68 h . 
Minimum essentia l medium (25 J.LI ) con ta ining 1.0 J.LC i tritiated 
thym idin e (sp act 1. 9 C i/ mmol, Schwartz/ Mann) was added to 
each well. C ul tures were incubated for 4 additio nal ho urs. Me-
diulll fro m each wel l was then aspirated, and monolayers were 
was hed 3 times at room temperature with GGBS. Plates we re 
allowed to dry and were sprayed with cl ea r lacquer. The bottom 
of each we ll was pun ched o ut , dissolved in Aquasol (10 ml , N ew 
Eng land Nuclear), chilled for 4 h at 4°C, and counted in a liquid 
scintillatio n co unter. Label ing ofsynthcs izcd and secreted proteins 
with J]-I-Iabc\ed amino acids was perfo rm ed as prev io usly de-
scribed [9\. 
Effect of SIFM on Adhesion and Spreading of Fibroblasts 
To determine w hether SIFM was exertin g its effect on mi g ration 
by alterin g fibroblast adhesion to and spread ing o n the po lycar-
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Serum Dilution 
bonate fi lters used in th e mi g rati on and chem otax is assay, we 
removed filters fro m ehambers containin g either SIFM (15 U / Il1I ) 
or GGBS in th eir low er co m pa rtm ents, vigo rously dipped th e 
fi lters in GG BS X 10, stained th e remaining cell s w ith hema tox-
ylin , counted th e cell s on th e upper surfJ ce of the filters in 20 
O IF, and exa mined their m orphology. The contents of the lower 
compartm ents o f the chamber were exa mined microsco pica ll y to 
determin e whether fibroblas ts had fa ll en o ff of the filters in th e 
presence of SIFM . 
RESULTS 
Effect of SerUlTI on Rando .. n Migration and Chemotaxis of 
Fibroblasts Different diluti ons of nOrll131 human se rum we re 
added to th e low er compartm ent o f chem ota xis chambers, and 
the rand om mig rati on (to medium) and chemota xis (to gelatin) 
of fib ro blasts were assessed. Serum inhibited bo th the rando m 
mig ration and chem otax is o ffibro blas ts in a dose-depend ent man-
ner (Fig 1). M aximal inhibition was observed at serum d ilutions 
of 1 :400 o r less (Fi g 1) . 
T o determin e whether no rmal human se rum would inhibit th e 
mig ration of fibro blasts fro m different dono rs, 7 rand oml y se-
lected fo reskin fibr oblast lines w ere studied. When tes ted at a 
1 :100 and 1:200 diluti on, no rm al human se rum inhibited bo th 
chem otacti c and rand o m mi g rati on of all 7 fibroblas t lines (data 
omitted) . T his sugges ts that th e susceptibility of hum an fibro-
blas ts to th e inhibito ry effects o f human serum is likel y to be a 
uni versa l pheno menon. 
It was o f interest to determin e w hether serum fro m di ffe rent 
dono rs contained the inhibito ry ac tivity. Serulll at dilutions of 
1:1 00 and 1 :200 from male and fem ale donors rang ing in age fro lll 
23- 63 yea rs effecti vely inhibi ted the chemota xis and rand om mi-
1 :800 MedIum 
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Figure 1. Fresh serum was obtained fro m 
a no rm al vo lunteer and added at diffe rent 
dilu tions to the lower co mpartment of mod-
ified Boyden chambers together with GGBS 
(OpC II circles) o r gelatin (closed circles) to assess 
the effect on the rando m migration and che-
mo tax is of dermal fib rob lasts. 
g rati on of fibroblasts (data omitted). This suggests th at SIFM is 
a no rmal component o f hum an serum . 
Partial Purification ofSIFM Steps fo llowed in the purifi ca tion 
o f SIFM arc summari zed in Table I. T hirty-three percent of the 
SIFM activity o riginall y present in serum was recovered in th e 
35-55% ammonium sul fa te precipitate. O ther ammonium sul fate 
fracti ons were devoid of SIFM acti v ity. O nl y a sm all deg ree o f 
purifi ca tion (1.3-fo ld) was realized by thi s procedure. 
Preparati ve gel filtration employing Sephadex G-1 50 removed 
th e majo r po rtion of contaminatin g albumin and o ther small pro-
te ins. All of the biologic activity of SIFM was recovered in th e 
vo id vo lume, and there was a 32.7-fo ld increase in specifi c acti vity 
(Fi g 2, Ta ble I). 
T he maj o r po rtion of Sephadex G-1 50-purifi ed SIFM bound 
to DE52-cellulose at low ioni c strength. E lution w ith 0.2 M N aCI 
recovered 46 .6% of SIFM applied to th e column , and there was 
a 30% decrease in specifi c ac tivity (Fig 3, T able I). 
Active fr3cti ons pooled from anion exchange chromatograph y 
were subjected to preparative fl atbed IEF. Three maj o r pro tein 
bands at pI 4.6, 4.9, and 5.1 were o bserved (Fig 4) . T he SIFM 
mi grated principall y to the pI o f 4.8 (Fig 4) . Frac tions containing 
SI PM w hen pooled together contained 29% of the loaded protein 
and 10.6% of th e to tal biolog ic activity subj ected to IE F (Table 
I). T here was an additional 64% decrease in specifi c ac ti vity , 
sugges tin g that IE F ca used SIFM to undergo significant dena-
turati on. 
Seph3dex G-200 chro matograph y o f IE F-puri fied SIFM was 
perfo rmed tw ice and res ulted in a 5-fo ld increase in specifi c ac-
ti vity ove r th at attained in the IEF step (Fig 5, Ta ble I). 
T his purifica tion scheme resulted in a fin al 54.3-fo ld purifi ca-
tion of SI FM and a reco very of 0.92% o f the bio logic ac ti vity 
Table I. Purifi ca ti on Scheme fo r SIFM" 
Fractio n 
Who le human serulll 
35-55% Ammo nium sul fa te 
G-1 50 
DE52-Ccllulosc 
Isoclectri c focusing 
G 200 #1 
G 200 # 2 
Tota l Protei n 
(mg) 
38,300 
<) ,800 
3 18 
212 
6 1. 6 
17.5 
6.5 1 
Total Acti vit yi' 
(uni ts) 
147,680 
48,780 
51,740 
24, 11 5 
2,548 
1,365 
1,365 
"Sec J\1ntrrials (lwl Nlcl/wds for de tails rega rd ing the purific:lt io ll proced ures. 
Specific Activity 
(uni ts/mg protein) 
3.86 
4.98 
162.7 
11 3.8 
4 1. 4 
78.0 
209.7 
From Total 
100 
33 
35 
16 
1.7 
0.92 
0.92 
Recovery 
Fro m Previous Step 
33 
106 
46.6 
10.6 
53 .6 
100 
bO ne unit o f act ivity is defi ned :IS thc :l Ill Ollllt o f lI1 ;} tcri :1 1 present th nt wi ll g ive 50% illhibition o f mi g rati o n in :l standard :lssay w here spo n ta neolls mi g rat io n is m eas ured. 
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Figure 2. Serum inhibitor of fibroblast migration (318 mg of protein) , 
precipitated from norma l serum by 35-55% ammonium sulfate, was 
applied to a preparative column (4.5 cm in diameter and 54 cm in length) 
fill ed with Sephadex G-150 (see Materia ls alld Metlrods). Aliquots of eluted 
fra ctions were dialyzed against GGBS and assayed at a 1:4 dilution for 
their ability to inhibit fibroblast migra tion. 
o ri g inally present in the serum from w hich it was purified (Tab le 
I) . This schem e did not res ult in a homogeno us preparation o f 
SIFM. E lectropho resis of the fmal product on sodium dodecyl 
sulfate po lyacrylamide gels yielded 3 distinct bands after si lver 
staining (data no t shown) . 
Physiochemical Properties of SIFM Since SIFM eluted nea r 
the void vo lume o n Sephadex G-200 (Fig 5) , ammo nium sulfate-
purified S IFM w as chromatog raphed on a column packed with 
Bio- Gel AI.5M in an effo rt to est imate its molecular weig ht more 
accurate ly. T he SIFM activity eluted fro m the AI.5M co lumn 
with proteins ha ving M, 230,000 (data not show n). Trea tment of 
SIFM with trypsin des troyed its bio logic ac ti vity , sugges tin g th at 
it is a protein (Table II ). Serum inhibi tor of fibrobl as t mi gration 
is a relatively hea t-stable protein . Its biologic activity remain ed 
after heatin g to 56°C fo r 45 min o r 80°C for 3 min (Table II). 
Effect of SIFM on Fibroblast Growth, Viability, and Pro-
tein Synthesis It was essential to determin e whether SIFM was 
exerting its inhibi tory effect on fibrobla st mig ratio n by actin g as 
a cytotoxic facto r. Fibroblasts exposed to SIFM under the same 
conditio ns used in the chemotax is assay were >83% viable by 
trypan blue exclusion. Incubation of fibrobla sts with SIFM for 
72 h in th e absence of serum did not alter their rate of tritiated 
thymidin e in corpora tion or protein synthesis (Tab le III). C ultur-
Figure 3. Serum inhibitor of fibrob last mi gration, 
partiall y purifi ed by ammonium sul fa te precipita-
tion, preparative gel fi ltration on Sephadex G-150 
(212 mg of protein) was loaded onto a colum n (2. 5 
cm diameter and 10 cm length) packed with DE-
52 cellulose (see Materials alld Methods). Proteins 
were eluted by a stepwise gradient as indicated. 
Aliquots of eluted fraction s were dialyzed against 
GGBS and tested for their ab ility to inhibit fibro-
blast migration. 
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Figure 4. Serum inhibi to r of fibroblast migration, partially purified by 
ammonjum sul fate precipitation, prepa rati ve gel filtration on Sephadex 
G-150, and anion exchange chromatograph y on DE52-cellulose was ap-
plied to a fl atbed IEF appara tus as described in Materials alld Methods. 
O ptica l density at 280 nm and ability of each fraction to inhibit random 
migration of fibroblasts were measured after extensive dialysis of the 
fractions against GGBS. 
in g fibrob lasts for 24 h in th e presence ofSIFM had an inhibitory 
effect on the in co rporation of 3H-labeled amino acids into tri-
chloroa cetic acid-precipitab le mate rial, suggesting that pro tein 
synthesis w as not inhibited (Ta ble Ill ). 
Fibroblast Adherence and Spreading Serum inhibi tor of fi-
broblas t mi g ratio n could theo retica Uy exert its effect o n migration 
by diminishin g the ability o f fibrob lasts to adhere to and spread 
o n th e surfaces of the chem o tax is filters . To determin e whether 
this w as th e case, we added SI FM or GGBS to the lo w er (tes t) 
compartm ents of the chemotaxis chamber and, after a 4-h in-
cubation , qu antitated and observed the m o rphologic appearan ce 
of fibrobl as ts adherin g after vigorous washin g to the upper surfa ce 
of th e filter in addition to countin g th e fibrobla sts that migrated 
to the lower surface of the filters. W e also quantitated the fibro-
blasts in suspension in the lower compartm ent of each modified 
Boyden chemota xis chamber. There was no signifi cant difference 
in the number of fibrobla sts ad herin g to th e upper surface of 
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Figure 5. As a final purifica tion step (see Table Ill), SIFM was chro-
matographed twice on a column 2.5 cm in diameter and 100 cm in length 
packed with Sephadex G-200 (sec Materials aud Methods). This graph shows 
the elution profil e of the second chromatographic run . 
Table II. Effect o f Trypsin and H ea t on the Biolog ic Activity 
ofSIFM 
Condition" 
Experiment 1 
M edium 
SIFM + trypsin + 37"C for 150 
min + SBTI 
SIFM + SBTI + 37°C fo r 150 
min + trypsin 
Experiment 2 
Medium 
SIFM (10 units) 
SIFM (10 units) + 56°C, 45 min 
SIFM (10 units) + 80°C, 3 min 
Fibroblast Migration 
Cells per 20 O IFb 
(mean ± SEM) 
. Gelatin 
(20 mg/ml) 
45 ± 4 
42 ± 3 
5 ± 
59 ± 2 
I ± 1 
10 ± 2 
10 ± 2 
Medium 
19 ± 
17 ± 
± 
31 ± 3 
o 
o 
o 
Ufn exper;mew 1, partiall y puri fied se rum inhibito r of fi bro blast m igra tion (S IFM ) 
(10 ).Lg. 14.7 units) was incubated w ith TPC K-Trypsin (2 ).Lg. 20 units. Sigma 
C hemica l Co. ) at 37°C (o r 150 min . Trypsin was then inacti va ted by additio n o ( 
10 ).Lg soybean tryps in inhibito r (SBTI). As a co ntro l. the o rder o f additi o n o( 
trypsi n and SBTI was reversed (Sec Materials (/1/(1 Methods). In expcrilllellt 2, partiall y 
purified SIFM was heated to 56°C (or 45 m in and 10 80°C (o r 3 min . H eat-trea ted 
and untrea ted SIFM was then tested fo r its ability to inhibit spontaneous migration 
and chemo tactic mig ratio n o( fib ro blasts to gelatin . 
'OIF. o il im mersio n ficids. 
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filters rem oved from chambers containing SIFM o r GGB S (Ta ble 
IV) . The number o f fibroblasts recovered fro m the lower com-
partments o f the chambers w as the sa m e fo r th ose containing 
SIFM o r GGB S (Table IV). In additio n, SIFM did no t alte r the 
degree of spreadin g exhibited by fibro blasts o n the upper surface 
o f filters (data not shown) . 
Reversibility of SIFM Effect on Fibroblast Migration T o 
assess the reversibility o f the effect of SIFM , harves ted fibro blas ts 
suspend ed in serum-free M E M were exposed for 1 h at 37"C to 
SIFM (10 U / ml) o r GGB S (10% by volume) as a control. The 
fibroblas ts w ere either w ashed or not washed befo re th ey were 
tes ted fo r th eir ability to respond to a chem otacti c stimulus. Fi-
broblasts preincubated w ith SIFM and then w ashed and sus-
pended in serum-free ME M migrated in a no rm al fashion w hil e 
th ose fibro blas ts left in contac t with SIFM were inhibited ill th eir 
mig ratio n (data o mitted) . 
Effect of SIFM on Migration of Fibroblasts to Different 
Chemoattractants The data thu s fa r cl ea rl y dem onstrate that 
SIFM inhibits rando m mig ration and chem o taxis of fibroblasts 
to denatured type I collagen. Parti ally purified SIFM w as tes ted 
fo r its ability to inhibit fibro bl as t mig ration to o ther chem oa t-
tractants and was found to co mpletel y inhibit th e mi gration of 
fibrobl as ts to w ard LDC F-F, type III co llagen, SD C F, and flbro-
nectin (T able V). These data sugges t tha t SIFM has a generalized 
effect o n fibro blas t locom o tion , inhibiting no t onl y rand o m mi-
grati on but also chem o taxis to ward different attractants. 
Specificity of SIFM A number of inhibi to rs of leukocyte che-
m otaxis have been fo und in serum of no rm al individuals and 
patients with diffe rent systemic diseases [1 0- 26). In view of this, 
we perfo rm ed a series o f ex periments to determine the effect of 
SIFM on the chem o taxis of hum an m onocytes and neutro phi ls. 
The effect ofSIFM o n the chem o taxis o f m o nocytes to parti all y 
purified C Sa, gelatin , and ka ll ik rein , and of neutrophi ls to par-
tiall y purified C 5a was assessed . The SIFM did no t inhibit the 
mig ration of m o nocytes o r neutrophils to these chem oa ttrac tants 
(T able VI). These data suggest that SIFM has cellular specificity 
fo r fibrobla sts and does no t inhibit neutro phil o r monocyte che-
motaxIs. 
DI SC U SSI O N 
Human serum contains a lVI, 230,000 hea t-stable protein that ex-
erts a po tent but reversibl e inhibito ry effect on bo th the rando m 
and chem o tactic mig rati on of fibro blas ts in vitro. Serum inhibi to r 
of fibroblast mig ration has no effect on the chem otaxis o f human 
' neutrophils o r m onocytes. 
The m echanism(s) b y w hich SIFM exerts its effect on fibro-
bl as ts is (a re) unknown. It w o uld appea r unlikely th at SIFM in-
acti va tes chemoa ttractants b y acting as a ligand sin ce th ere are no 
apparent similarities between the fib roblas t chemoattractants tes ted 
Table III. Effect of SIFM o n Fibro blas t Viability, G rowth , and Pro tein Synthes is 
Condition 
Fibroblas t + GGBS,t 
Fibroblas t + SIFM' 
(15 units/ ml) 
T rypan Blue 
Exclusion" 
(mean % ± SEM) 
75 ± 10 
75 ± 8 
[3H [Thymidine 
Uptake" 
(mean CRP ± SEM) 
1530 ± 11 6 
1380 ± 136 
[3H[Amino Acid 
In corporation' 
(mean CPM ± SEM) 
926 ± 32 
1278 ± 81 
'T rypa n blue exci usio n was determined after fi b rob lasts suspended in M EM we re incubated in tri pli cate for 3 h at 37°C w ith GGBS Or SIFM . 
' Fibroblasts at subconfluent density were cultured with GG BS o r SIFM fo r 72 h. T ritiated th ymidine was added to cultures fo r th e last 4 h . and uptake by fibrob lasts 
was deter mined as described in Materials allli Metllods. 
'Fibroblasts were seeded at a density o r 8 x 10' cells per well in a Fa lco n 3008 multiwcll plate and grown (or 24 h in maintenance med ium contain ing 10% (etal cal( 
serum. C ell l11o no la yc rs were then washed x 3 w ith serum- free m aintenance med ium. Serum inh ibitor of fi b roblast m igration or CGBS in a volume of 50 ILl were added 
to sepa rate wells in tripli ca te containin g serum-free maintenance medium 450 ILl w ith 5 ).LC i o ( a m ixture o( ' H-bbcled amino acids. H arvested supe rn atants were exposed 
to cold 10% trichlo roacetic acid (TC A) and precipitates were collected o n Whatman 3MM scintillatio n pads. was hed X 3 w ith 10 ).L1 o( cold T CA. dried. and subjected to 
scin riJJario n counting. 
'GGBS. 0.0075 M g lycig lycinc/0. 14 M N aCI. pH 7.2. 
'S IFM . serum inhibito r o ( fibro blast mig ratio n. 
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Table IV. Effect of SIFM 0 11 Fibrob las t Adheren ce to 
C hemotax is Fi lters 
Fibroblasts per 20 O IF ( m e~ Jl ± SEM ) 
Condi ti o n 
GGBS 
SIFM ( 15 uni ts/ ml) 
Upper Su rface 
1288 ± 98 
1338 ± 86 
Lower Sur face 
62 ± 5 
2 ± 0.6 
C he m otax is chambers we re se t li p in t ripli ca te w ith cithe r GGI3S or S IFM in th c 
lower (lcs t) compartm C'll ts as described in NlnlL'I"inls and }\Ilt'l llm/s. After 4-11 incu-
b:lrion , filters were re moved from the chambers all d we re vigo rously d ipped X 10 
in GGUS prior to be ing sta in ed . Fibroblasts 0 11 the LIppe r and lowe r sLlr r.,ces ill a 
tota l of 20 ra ndomly selected fldds 0 11 each side of die fi lte r we re counted. 
AbbreviJt io ns: GGI3S. 0.0075 M g lycy lg lycin e!0 . 14 M NaC I. pH 7.2. 
O IF. o il imme rsion field s. 
SIFM , sCI"um inhibitor or fibrobla sr rni gr:lti o n . 
(i. e., co llagen, fibrone ctin , LDCF-F, and SDCF), and the che-
motactic res po nse of human mo nocytes to denatured co ll agen is 
no t inhibited by SI FM w hile the chemotactic mi grati on o f fibro-
blasts to denatured co ll agen is inhibi ted by SIFM . IfS IFM exerts 
its effe ct by binding chem oattractants, it should block the re-
sponse of fibrob lasts and mo nocytes to denatu red co llagen. It is 
also unlikely that SIFM is a protease that no nspecifi ca ll y des troys 
chemoa ttrac tants, s in ce it had no effect o n th e chemo ta cti c po-
ten cy of C5a o r ka llikrein , and peptides generated by such deg-
radatio n o f denatured coll agen would still reta in chemotacti c ac-
tivity for fibro blasts r1] . In add iti o n, we have o bserved that SIFM 
purified by am lllo nium sulfate precipitation and Sephadex G-1S0 
chro m atograph y docs no t deg rade azocasein (unpublished o bse r-
vat io n) . 
Since SIFM docs not appea r to exert its effect by " inactivating" 
fibro blas t chemoattractants, it seems reasonable to pos tulate that 
SIFM interacts directly in so me specifi c way w ith the fibrobla st 
and rend ers it in ca pable of mig rati o n. T he notio n that SIFM 
interacts specifi call y w ith fibrob lasts is suppo rted by o ur o bser-
vatio n that it has no no ticeable effect o n neutrophil o r mo nocyte 
chemo tax is and that it inhibits fibro blast but no t mo nocy te che-
mo ta xis to denatured collagen. Cell-surface interaction w ith SIFM 
could occur through bindin g to a specifi c recepto r o n th e fibro-
blast. T his co uld res ult in defective celi-substrate interacti o n to 
decrease adhesion. T his mi ght impair the ability of lamillopodia 
to attach to substrate and thereby decrease fibro blast mig rat io n. 
Althou g h thi s wo ul d appea r to be an att ra ctive hypo th es is, its 
va li d ity is qu estio nable sin ce we observed that SIFM has no effect 
Table V. Effect of SIFM on Hesponse of Fib rob lasts to 
Different C hemoattractants 
Cond it io n" 
Buffe r 
Buffer + SIFM 
LDCF-F (80 J.LI ) 
LDCF-Io + SIFM 
SDCF (80 J.LI ) 
SDCF + SIFM 
Fibro nectin (1 J.Lg/ ml ) 
Fibronectin + SIFM 
Type III co llagen (200 J.Lg/ l11l ) 
T ype III co ll agen + SIFM 
C hem o tacti c Acti vity (M ea n ± SE M ) 
Fibroblasts per 20 O IF 
17 ± 2 
o 
45 ± 4 
o 
5] ± 3 
o 
73 ± 5 
o 
63 ± 2 
o 
"A 1.5 M purified SIFM (16 "nits) was added to buffer (GG13S) or chclll o:lt tra ctallt 
an d p b ccd in th e lowe r co m part ment of chclll or:tx is chambt.:rs as indi cated . C he-
Ill o;ltl'rac[:t n [s were prepared as described in A4fltL'I'inh a/UI AI/('Ili ods. 
Abbreviatio ns: LJ)CF~F. ly m phocy te-derived chelllotactic f., cto r ror fi broblasts. 
O IF. o il ill1 llle rs io n fi eld s. 
SDCF, serum-deri ved clic lll ot:JC[ic f:lClor. 
S IFM. serulll inhi bitor of nb ro blast mig rati o n . 
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Table VI. Effect o f SIFM on Mo nocyte and 
N eutrop hil C hemotax is" 
Condition!' 
Ex pe riment I 
C5a 
C5a + SIFM (15 uni ts!ml) 
C5a + SIFM ( 10 units/ ml ) 
GGBS 
Experimen t 2 
Gelatin 
Ge latin + SIIOM ( 15 units/ ml) 
Gel atin + SIFM (10 units/ ml ) 
GGBS 
Ex periment 3 
Kallikrein 
Kallik re in + SIFM (15 units/ml ) 
GGB S 
C hem o tactic Acti v ity 
(m ean ± SEM ) 
N eutrophil s 
per 5 O l IO 
62 :!: 2 
74 ± 14 
69 :!: 9 
13 :!: 2 
Mon ocytes 
per 5 O IF 
126 ± 14 
136 ± 13 
11 6 ± 8 
18 ± 2 
109 ± 12 
103 ± 9 
11 0 ± 14 
11 + 2 
122 ± 11 
132 ± 15 
10 ± 
"ASS ;1 Y fo r huma n m o nocy te alld neutroph il che m o ta xis W:1S perfo rm ed as de-
scribed previo usl y 126,27 1. C h elll otactic activ it y is ex pressed as th e n"lllber of 111 0 11 0_ 
cy tes o r Ilelltrophil s present On th e lower slIr r.,ce of po lycarbo llate fi lters (S-J.l.111 
po res) in 5 rando llll y selected mi croscopic fi elds (600 X ll1a g nifi cat io n). 
"C5a was prepared by fra ctl on:H.ing zy m os;m-actlv;u cd human serum o n a CO\ U11111 
pa cked w ith Sephadcx G-200 131. T he co ncelltr3tio n of gelatin was 5 m g! ml an d 
o f kallikrein . 125 /Lg! ml. Thcse che m o att",cta llts we re pla ced w ith and w ith o ut 
SIFM ill the lowe r co mpartmcnt or m odified 130ydcn chambe rs, and che mo taxis 
was q uall t ifi ed . 
Abbrev iations: GGBS. 0.0075 M g lycy lg lycin c!0. 14 M NaC I. pH 7.2. 
O IF. o il immc rs io ll fields. 
S IFM. serum inhibito r o f fibro bla st l11ig ratio ll . 
in vi tro on the ab ilit y of fibro blasts to synth esize proteins, rep-
li ca te, o r grow as mon o la ycrs in culture. In addition , we did not 
find th at SIFM alters adhes io n o f fibro blas ts to po lycarbonate 
filters or affects thc spread in g of fibro blasts. Alternativel y, the 
interaction ofSI FM w ith a cell surface recepto r mi ght th eo reti ca ll y 
tri gge r a chain of biochemi ca l events th at in som e way co ul d turn 
off th e locomotive apparatus of the fibrobla s t. There arc no data 
to suppo rt this hypoth esis at presen t. 
Numero us factors mediate or modulate bio logic res ponses in 
specific types o finfl aml11 ato ry react io ns. T hese include vasoactive 
am ines, leukoki nins, kin ins, co mpl ement, anap hylatoxins, pros-
tag landins, Iymphokincs, bacterial produ cts , conn ective tissue 
matri x, and perhaps other unrecog nized substa nces r27-42J. It is 
believed that these medi ato rs playa signifi cant ro le in effectin g 
an exudati on and sequ estrati on o f neutro phil s and m acroph ages 
at sites of infl amJ1lato ry reactions in vivo. N eutro phil s and mono-
cy tes secrete enzy mes (proteinases, coliagenases, g lycosidases) ca-
pable of degradin g matrix constituents (e.g. , collagens, mu co-
po lysaccharides, and fib ronectin) to small fra gments 143-46). 
T he repair process oecllrring after infl ammation in conn ccti ve 
tissue is charac terized by mi g ratio n o f neighbo rin g fibro blasts (or 
myo fibro blasts) into th e reaction site, perh aps in response to spe-
ci fi c chemoa ttra ctants 147-49]. Fibroblas ts also expand th eir po p-
ulation at sites o f inflammation by undergoin g mitosis 150-52). 
The infl ammatory lesio ns in connective tissue arc repaired by 
fibro blasts as they synthes ize, lay down , and remodel new matri x. 
Most, if not all , ph ys io logic processes requ ire both pos iti ve 
and negative co ntro ls. The SIFM may fun ctio n as an impo rtan t 
modu lato r of fibro blast mi g ratio n in vivo in mu ch th e sa me way 
as chemotactic factor inactivator and cell-directed inhibito rs m ay 
regulate leukocy te chemo ta xis. T he f.1Ct th at SIFM is a trypsin-
sensitive protein suggests that it mig ht be degraded at sites of 
inflammatory reaction s by the action o f pro teinases fro m neutro-
phils and /o r macrophages. T his woul d all ow local fibroblasts to 
respond to chemotactic signals generated durin g the inflammatory 
reactio n. Future studies dea ling with the ro le SIFM plays in the 
VOL. 88. N O.2 FEI3RUARY 1987 
modulation of fibrobIJ st mig ratio n mig ht provide use fu l in sig hts 
II1to the nature o f diseases o r co nditi ons charac teri zed by excess ive 
fibrosis o r in adeq uate wound hea li ng. 
T he alllhors ackll v ,,, l c((Qc II, e excel/cIII la hllira l (/SS i51(/ II C(, "J SlIsa ll T il,.,, (/' , 
Cylllhi(/ C arIeI', Palricia Ocall , (/ Ild Palrici(/ C lllllil'/c/llski . 
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